InterVivo Solutions
Business Services · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
PO Box 248, Fergus, Ontario, N1M 1N0, Ca...Phone Number
(416) 677-6085Website
www.intervivo.comRevenue
$17.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About InterVivo Solutions
Transpharmation is a preclinical neuroscience contract research organization (CRO) that specializes in accelerating drug discovery programs through high-quality translational biology services. They offer a robust suite of animal models and expertise in drug development research, providing reliable and clinically relevant data to enhance preclinical assets. With access to the largest laboratory beagle colony, they assess naturally developing age-related diseases like Alzheimer's and osteoarthritic pain. Their services cater to pharmaceutical companies and researchers seeking innovative solutions in various neuroscience-related areas, ensuring an integral partnership throughout the drug discovery process.Explore more
InterVivo Solutions Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is InterVivo Solutions your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if InterVivo Solutions had a recent Job posting/layoffs
Earning: See what the market has to say on InterVivo Solutions recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at InterVivo Solutions
InterVivo Solutions, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once InterVivo Solutions has new funding data
Product Launch: Get notified when InterVivo Solutions launches new products
Check if InterVivo Solutions has recently received funding, and reach out quickly before it becomes old news!
Check out if InterVivo Solutions is spiking on competitors!
Recommended Actions
Find VP level buyers at InterVivo Solutions
Find more new buyers
Compare Similar Companies to InterVivo Solutions
Compare insights from companies similar to InterVivo Solutions, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
InterVivo Solutions is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
InterVivo Solutions is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about InterVivo Solutions.
InterVivo Solutions Tech Stack
InterVivo Solutions News & Media
Mindset and InterVivo Solutions Announce Availability of First Preclinical Psychedelic Benchmark Data from COPE Program
TORONTO, June 14, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, and InterVivo Solutions (“InterVivo”), today announced the availability of their first data set as part of the Cooperative Psychedelics Evaluation Platform (“COPE”) prograInterVivo Solutions Provides Update on Cooperative Psychedelics Evaluation Platform (COPE) - Names Drs. Inés De Lannoy and Lilia Magomedova to Lead Bioanalytical Platform Development
Toronto, Ontario--(Newsfile Corp. - June 12, 2021) - InterVivo Solutions (IVS) today announced availability of its first data set as part of the COPETM program. The program, launched in March, in collaboration with Mindset Pharma Inc. (CSE: MSET) aims to create the world's first preclinical behavioral and pharmacokinetics benchmark data for clinically relevant psychedelic drugs including Psilocybin, LSD, DMT, and 5-MeO-DMT amongst others. Preliminary data released today focused on Psilocybin/PsiMindset Pharma and InterVivo Solutions to Jointly Develop Advanced Cooperative Psychedelics Evaluation Platform ("Cope"); Cope Expected to Be World's First in Vivo Psychedelic Benchmark Data Set
Toronto, Ontario--(Newsfile Corp. - March 23, 2021) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a biotechnology company focused on developing next generation psychedelic medicines and related technologies, is pleased to announce that it has entered a co-development agreement with InterVivo Solutions Inc. ("InterVivo" or "IVS"), to co-develop a new translational testing platform that Mindset and InterVivo expect will introduce an industry standard agaInterVivo Solutions and Mindset Pharma to Jointly Develop Advanced Cooperative Psychedelics Evaluation Platform ("COPE")
Toronto, Ontario--(Newsfile Corp. - March 23, 2021) - InterVivo Solutions Inc. ("InterVivo" or "IVS" or the "Company"), a leading Canadian contract research organization providing preclinical in vivo research services that enable the pharmaceutical and nutraceutical industries to develop new products and therapies for neuropsychiatric and neurological diseases, is pleased to announce that it has entered a co-development agreement with Mindset Pharma Inc. (CSE: MSET) ("Mindset") to co-develop a n
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding InterVivo Solutions
Sign Up For FreeTo access detailed company insights
Transpharmation is a preclinical neuroscience contract research organization (CRO) that specializes in accelerating drug discovery programs through high-quality translational biology services. They offer a robust suite of animal models and expertise in drug development research, providing reliable and clinically relevant data to enhance preclinical... Read More
